Lupin forms Joint Venture with Japan's Yoshindo Inc

Lupin's Etanercept biosimilar, developed by its Biotechnology Research Group in Pune will be the first product to be licensed for clinical development to YLB.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news